Table 2.

Apoptosis Induced by Idarubicin 50 μg/L After 24 hours: Mean % Cells Apoptotic (SD)

Cell Line/TreatmentControlGM-CSFATRAATRA + GM-CSF1,25(OH)2 D31,25(OH)2 D3 + GM-CSF
HL60 n = 3 30.2 (9.5) 33.3 (12.3) 7.0 (1.2) 9.3 (1.6) 10.2 (5.1) 10.4 (4.7) 
U937 n = 7 27.9 (12.0) 21.6 (6.6) 13.1 (4.8) 4.2 (2.8) 21.9 (8.2) 9.2 (4.4) 
KG1 n = 3 30.1 (4.6) 32.0 (8.0) 8.3 (4.7) 15.1 (4.0) 11.8 (6.1) 16.7 (7.0) 
Cell Line/TreatmentControlGM-CSFATRAATRA + GM-CSF1,25(OH)2 D31,25(OH)2 D3 + GM-CSF
HL60 n = 3 30.2 (9.5) 33.3 (12.3) 7.0 (1.2) 9.3 (1.6) 10.2 (5.1) 10.4 (4.7) 
U937 n = 7 27.9 (12.0) 21.6 (6.6) 13.1 (4.8) 4.2 (2.8) 21.9 (8.2) 9.2 (4.4) 
KG1 n = 3 30.1 (4.6) 32.0 (8.0) 8.3 (4.7) 15.1 (4.0) 11.8 (6.1) 16.7 (7.0) 

ANOVA P values for ATRA, 1,25(OH)2 D3 and GM-CSF effects: ATRA-HL60 P = .02, U937 P < .001, KG1 P < .01; 1,25(OH)2 D3-HL60 P = .02, U937 P < .01, KG1 P < .01; GM-CSF-HL60 P = .02, U937 P < .001, KG1 P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal